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  Peplomycin， a new derivative of Bleomycin， was evaluated clinically for treatment ofpro－
state cancer patlents．
  Peplomycin was injected intramuscularly， 5 or 10 mg every other day， to 8 patients with
prostate cancer． Total dose ranged from 30 to 200 mg． According to Karnofsky’s criteria，
only one case was 1－B， other cases were in group O． Pulmonary fibrosis， one of the major
side effects of this drug， was experienced in 2 cases．
  This anticancer agent was injected directiy into the prostate， 20 mg once a week for 5
weeks， to 2 patients who were unrefractory to estrogen treatment and had lower urinary
obstruction for relief of local symptoms． One case was 1－A， and the other was 1－B． No
servere side effect was observed．
  Serum concentration of Peplomycin after administration was measured by a bioassay．
Serum ievels of Pepiomycin after a 1ocal injection of 20 mg and after one intravenous shot
of 10 mg were almost equal．











































































Table 1． Summary of cases treated with peplomycin i．m．
        Histological
Case Age ． diagnosis ． Stage
       （differentiation）
Previous
therapy
Total．dose Palpation of Karnofsky’sof Peplomycin






















































t All cases are adenocarcinomas of prostates
藤本・ほか＝前立腺癌・Peplomyci皿 1435
Table 2． Laboratory data before and after PEP treatment
Aikali phosphataseTotal aci．d phosphataseProstatic acid phosphatase
Case

























































 Alp ： 30－85 IUII
 Acp ： O一 9 IUfl
 PAP ： O一 1 nMol／min／ml
Case 8
 Alp ： 3－10 KA
 Acp ： 1一 4 KA

















PeplomycinをSilverman針にて1回IO mgを3       回前立腺癌組織内に局注（第1回治療）した．治療後
前立腺は直腸診上，鶏卵大に縮小し，排尿困難は改善
した．Fig．1は第1回治療前の尿道造影， Fig・2は












































   Fig． 7
























Alp， Acp， PAP IX・1981年以後正常範囲内にある．
Peplomycin局十時の体内動態











 成   績
 Peplomycin 20 mg局注後の血中濃度の推移は，






































Table 3． Serum concentration of Peplomycin （ptg／ml）
Time after administration
15 min． 30 min． 1 hr2hrs 4 hrs 24 hrs
  Lacal injection
in prostate of 20mg PEP
1．50 1．35 1．18 O．73 O．31 〈O．03
Intravenous injection
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